Clinical Trials 2026: The Ultimate Guide to Breakthrough Research
Explore the groundbreaking clinical trials of 2026, including Ziltivekimab and Daraxonrasib, and their transformative potential in medical treatments.
Category
Research & science
45 articles in this category
The Ultimate Guide to Groundbreaking Type 1 Diabetes Research in 2025
Discover groundbreaking advancements in Type 1 Diabetes research, including revolutionary therapies aiming to transform patient treatment and potentially achieve insulin independence.
Greenhouse Gas Regulations: Essential Health Implications
Explore the essential health implications of greenhouse gas regulations and their significant impact on public health and the environment.
Obesity Crisis: Essential Link to 10% of Global Infection Deaths
Groundbreaking research reveals obesity contributes to one in ten deaths from infectious diseases worldwide, highlighting an urgent public health crisis that demands immediate attention and intervention strategies.
Breakthrough Diabetes Research: Stanford Achieves Type 1 Cure in Mice
Stanford Medicine researchers have achieved a groundbreaking milestone by successfully curing type 1 diabetes in mice through an innovative immune system reset using blood stem cells, offering new hope for future human treatments.
Essential Insulin Trial Advances: Arecor Targets Phase II for 2026
Arecor Therapeutics announces strategic plans to advance its innovative insulin therapy into Phase II clinical trials by 2026, following successful 2025 developments that position the company at the forefront of diabetes treatment innovation.
Blood Metabolites: Revolutionary Diabetes Risk Prediction Method Discovered
Groundbreaking research reveals a 44-metabolite blood signature that predicts type 2 diabetes risk with unprecedented accuracy, potentially transforming preventive healthcare and early intervention strategies.
Essential Metformin Benefits: Diabetes Drug Reduces Vision Loss by 37%
Groundbreaking research from Liverpool reveals that metformin, a common diabetes medication, may reduce age-related macular degeneration by 37%, offering new hope for preserving eyesight in aging populations.
Essential Breakthrough: Encapsulated Islets Show Promise in Type 1 Diabetes Treatment
Encellin's Phase 1 clinical trial reveals groundbreaking results for encapsulated islet therapy in type 1 diabetes patients, demonstrating no fibrosis and opening new possibilities for cell-based treatments.